Internal Medicine, Medical Oncology · Waycross, GA
NPI
1497745632
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1206 Alice St
Waycross, GA, 31501
Phone (912) 285-1140
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.8M
403,970 services
Medicare patients, 2024
801
Average age 74
Drug cost, 2024
$5.4M
3,091 prescriptions
Company payments, 2025
$172
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asit K Jha was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 79,500 times for 50 patients. In total Asit K Jha billed 403,970 services in 132 codes, and Medicare paid $5.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 79,500 | 50 | $2.33 | $185K |
| J0185 Injection, aprepitant, 1 mg | Office | 25,220 | 40 | $1.35 | $34K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,500 | 17 | $44.35 | $865K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 16,100 | 140 | $15.78 | $254K |
| J9267 Injection, paclitaxel, 1 mg | Office | 10,971 | 11 | $0.08 | $895 |
| J0897 Injection, denosumab, 1 mg | Office | 9,000 | 57 | $20.60 | $185K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,445 | 62 | $0.09 | $309 |
| 85025 Blood Count | Office | 3,308 | 719 | $7.56 | $25K |
| 36415 Venipuncture Blood Collection | Office | 3,242 | 721 | $8.59 | $28K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,350 | 50 | $0.70 | $1,644 |
| 99213 Office E&M - Established | Office | 1,404 | 605 | $59.80 | $84K |
| 99214 Office E&M - Established | Office | 1,350 | 462 | $90.78 | $123K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,208 | 28 | $0.07 | $90.22 |
| Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg | Office | 1,068 | 20 | $154.02 | $164K |
| 96375 Injection Administration | Office | 961 | 78 | $10.40 | $9,995 |
By year: 2022 $3.2M for 244,133 services; 2023 $5.4M for 420,908 services; 2024 $5.8M for 403,970 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,308 | 719 | $7.56 | $25K |
| 36415 Venipuncture Blood Collection | 3,242 | 721 | $8.59 | $28K |
| 85045 Blood Count | 94 | 88 | $3.91 | $368 |
| 81002 Clinical Chemistry | 39 | 15 | $3.41 | $133 |
Medicare prescription drug claims, 2024
In 2024, the drug Asit K Jha prescribed most often to Medicare patients was Letrozole, with 374 prescriptions and refills. In total Asit K Jha wrote 3,091 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 374 | 628 | 90 | $6,086 |
| Eliquis Apixaban | 210 | 237 | 48 | $136K |
| Ondansetron Odt Ondansetron | 177 | 177 | 100 | $4,013 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 131 | 131 | 42 | $3,329 |
| Acyclovir Generic | 117 | 161 | 26 | $1,590 |
| Dexamethasone Generic | 110 | 110 | 27 | $976 |
| Prednisone Generic | 108 | 133 | 38 | $537 |
| Anastrozole Generic | 104 | 187 | 32 | $1,253 |
| Revlimid Lenalidomide | 93 | 93 | 11 | $1.5M |
| Olanzapine Generic | 79 | 85 | 33 | $638 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 78 | 78 | 16 | $1,582 |
| Abiraterone Acetate Generic | 76 | 76 | Under 11 | $100K |
| Gabapentin Generic | 64 | 71 | 17 | $446 |
| Hydroxyurea Generic | 57 | 94 | 18 | $1,041 |
| Morphine Sulfate Er Morphine Sulfate | 53 | 53 | 12 | $1,409 |
Brand drugs: 687 claims; generic drugs: 2,404 claims; opioid claims: 360.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asit K Jha $172 ($172 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 5 | $172 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.